The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | H | Systemic hormonal preparations, excl. Sex hormones and insulins | |
| 2 | H02 | Corticosteroids for systemic use | |
| 3 | H02A | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN | |
| 4 | H02AB | Glucocorticoids | |
| 5 | H02AB06 | Prednisolone |
The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.
| Route | Amount |
|---|---|
| ORAL - Oral | 10 mg |
| PAREN - Parenteral | 10 mg |
| Active Ingredient | Description | |
|---|---|---|
| Prednisolone |
Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DELTACORTRIL ENTERIC Gastro-resistant tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| DILACORT Gastro-resistant tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| MEDOPRED Solution for injection / infusion | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| MEDOPRED Tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
| PEDIAPRED Oral solution | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
| REDIPRED Oral solution | Medicines and Medical Devices Safety Authority (NZ) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
